Mirati Therapeutics, Inc.·4

Mar 13, 6:00 PM ET

Donadio Jamie A 4

4 · Mirati Therapeutics, Inc. · Filed Mar 13, 2018

Insider Transaction Report

Form 4
Period: 2018-03-09
Donadio Jamie A
VP of Finance
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2018-03-0912,1001,100 total
    Exercise: $17.41Exp: 2024-05-20Common Stock (12,100 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-09$17.41/sh+12,100$210,66112,100 total
  • Sale

    Common Stock

    2018-03-09$35.00/sh12,100$423,5000 total
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017.
  • [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter

Documents

1 file
  • 4
    marketforms-41360.xmlPrimary

    PRIMARY DOCUMENT